# Agomab Therapeutics

**Canonical:** https://apis.io/providers/agomab-therapeutics/  
**Website:** https://agomab.com/  
**APIs profiled:** 0

Agomab Therapeutics is a clinical-stage biopharmaceutical company (Nasdaq: AGMB) developing novel disease-modifying therapies for fibro-inflammatory diseases, with an initial focus on chronic fibrotic indications of high unmet medical need such as Crohn's disease and idiopathic pulmonary fibrosis. Building on deep expertise in growth factor biology, Agomab advances a pipeline of small-molecule and antibody candidates targeting the pathways that drive tissue fibrosis and inflammation. Headquartered in Belgium with operations across Europe and the United States, the company was surfaced as a portfolio company of Canaan Partners and added to the API Evangelist network. As a biopharmaceutical company it publishes a corporate and investor-relations web presence rather than a public developer API surface; this profile captures its identity and public web properties for the network catalog.

## Kin Score — 7.6 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 7.6).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Agomab Therapeutics Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biopharmaceutical, Biotechnology, Therapeutics, Fibrosis, Healthcare, Life Sciences, Drug Development

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/agomab-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.